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Background: Asbestos exposure is related to various diseases including asbestosis and malignant mesothelioma
(MM). Among the pathogenic mechanisms proposed by which asbestos can cause diseases involving epithelial and
mesothelial cells, the most widely accepted one is the generation of reactive oxygen species and/or depletion of
antioxidants like glutathione. It has also been demonstrated that asbestos can induce inflammation, perhaps due to
activation of inflammasomes.
Methods: The oxidation state of thioredoxin was analyzed by redox Western blot analysis and ROS generation was
assessed spectrophotometrically as a read-out of solubilized formazan produced by the reduction of nitrotetrazolium
blue (NTB) by superoxide. Quantitative real time PCR was used to assess changes in gene transcription.
Results: Here we demonstrate that crocidolite asbestos fibers oxidize the pool of the antioxidant, Thioredoxin-1 (Trx1),
which results in release of Thioredoxin Interacting Protein (TXNIP) and subsequent activation of inflammasomes
in human mesothelial cells. Exposure to crocidolite asbestos resulted in the depletion of reduced Trx1 in human
peritoneal mesothelial (LP9/hTERT) cells. Pretreatment with the antioxidant dehydroascorbic acid (a reactive oxygen
species (ROS) scavenger) reduced the level of crocidolite asbestos-induced Trx1 oxidation as well as the depletion of
reduced Trx1. Increasing Trx1 expression levels using a Trx1 over-expression vector, reduced the extent of Trx1 oxidation
and generation of ROS by crocidolite asbestos, and increased cell survival. In addition, knockdown of TXNIP expression
by siRNA attenuated crocidolite asbestos-induced activation of the inflammasome.
Conclusion: Our novel findings suggest that extensive Trx1 oxidation and TXNIP dissociation may be one of the
mechanisms by which crocidolite asbestos activates the inflammasome and helps in development of MM.
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Malignant mesothelioma (MM) is a deadly cancer arising
from the mesothelium and its etiology usually involves
asbestos exposure [1]. MM is a very invasive and aggres-
sive disease that is chemo-resistant to most of the stand-
ard chemotherapeutic agents. Patients with MM typically
have a poor prognosis with a life expectancy of about 8-12
months after diagnosis [2]. Efforts at understanding how
asbestos exposure leads to the development of MM and
other malignancies have not definitively determined how* Correspondence: arti.shukla@uvm.edu
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article, unless otherwise stated.exposure leads to the formation and progression of this
unusual neoplasm. Studies have, however, shown that
apoptosis followed by compensatory proliferation and
chronic inflammation induced by asbestos fibers play a
major role in disease progression [3-5]. Chronic inflam-
mation induced by asbestos exposure is believed to be
involved in the pathogenic process that leads to asbestos
related diseases like MM [6,7]. Recent work from our
group has demonstrated that asbestos-induced inflam-
mation in mesothelial cells and machrophages could, in
part, be mediated by activation of the inflammasome, a
protein complex involved in the processing of cytokines
[8]. The exact mechanism by which asbestos activatestral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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reactive oxygen species (ROS) are believed to play a role
[5]. It has also been reported that a redox-regulated
protein, thioredoxin interacting protein (TXNIP) can
bind and activate the Nod-like receptor family pyrin
domain containing 3 (NLRP3) inflammasome [9]. ROS
induced in response to crocidolite asbestos exposure
have been shown to initially deplete intracellular levels
of reduced glutathione [10,11], but the effect of crocido-
lite asbestos on another major cellular antioxidant,
thioredoxin (Trx1) is unknown.
Thioredoxin is a small ubiquitously expressed redox
active protein that is important for maintaining the
reducing milieu of the cell, in part by reducing protein
disulfide bonds that occur in response to oxidative pro-
cesses. During reduction of disulfide bonds Trx1 itself
becomes oxidized and in turn reduced by thioredoxin
reductase (TR) using electrons from reduced nicotinamide
adenine dinucleotide phosphate (NADPH) [12]. Trx1 is
inhibited by thioredoxin interacting protein (TXNIP)
via a redox-dependent interaction [13,14]. TXNIP is
only capable of binding to and inhibiting Trx1 in its
reduced state [9,14]. In response to oxidative insults,
TXNIP has been shown to bind to and activate the
NLRP3 inflammasome [9]. Based on these observations
and the capacity for crocidolite asbestos fibers to generate
ROS intra- and extracellularly, we hypothesized that
crocidolite asbestos-induced ROS generation will oxidize
Trx1 causing its dissociation from TXNIP. As a result of
this dissociation, TXNIP would be free to bind to, and
activate, the NLRP3 inflammasome. Here, we show for the
first time, that crocidolite asbestos exposure leads to the
irreversible oxidation of Trx1 and depletes reduced
Trx1 levels in LP9/hTERT cells. We also show that
over-expression of Trx1 reduces levels of crocidolite
asbestos-induced ROS. Our results indicate that oxidation
of Trx1 by crocidolite asbestos results in dissociation of
TXNIP and subsequent activation of inflammasomes, as
knockdown of TXNIP by siRNA partially reduced cro-
cidolite asbestos-induced inflammasome activation as
indicated by a reduction in caspase-1 activation.
Materials and methods
Human LP9 mesothelial cells, an hTERT-immortalized
cell line that phenotypically and functionally resembles
normal human mesothelial cells, were obtained from
Dr. James Rheinwald (Brigham and Women’s Hospital,
Harvard University, Boston, MA). All cells were incu-
bated at 37°C in 5% CO2 and grown to 80–90% con-
fluency as described previously [15]. The physical and
chemical characterization of the National Institute on
Environmental Health Sciences (NIEHS) reference sample
of crocidolite asbestos has been reported previously [16].
The NIEHS chrysotile reference sample was used forasbestos fiber comparisons. After sterilization under UV
light overnight, particulates were suspended in Hank’s
balanced salt solution (HBSS) at 1 mg/ml, sonicated for
15 min in a water bath sonicator, and triturated five to
ten times through a 22-gauge needle. A volume of this
suspension was added to cells in medium to achieve the
desired final concentration of 75 × 106 μm2/cm2 dish
surface area, a concentration known to cause apoptosis
and compensatory proliferation of surrounding rat pleural
mesothelial and murine alveolar type II epithelial cells
[3,17]. Glass beads (Polysciences Inc, Warrington, PA)
were used as a non-pathogenic particle control. Dehy-
droascorbic acid (DHA) and 2,4-Dinitro-1-chlorobenzene
(DNCB) were purchased from Sigma (St. Louis, MO).
Trx1 expression vector (pCMV-SPORT6) and pcDNA
(empty vector control) used for over-expression studies
were obtained from Dr. Nicholas Heintz.
Western blot analyses
Cells grown in 60 mm culture dishes were washed 3×
with ice-cold phosphate buffered-saline (PBS), collected
in lysis buffer (20 mM Tris pH 7.6, 1% Triton X-100,
137 mM NaCl, 2 mM EDTA, 1 mM Na3O4V, 10 mM
NaF, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride,
10 μg/ml leupeptin, and 10 μg/ml aprotinin) and incu-
bated on ice for 30 min. Lysates were centrifuged at
14,000 rpm for 15 min at 4°C. Supernatants were col-
lected, and protein concentrations were determined
using the Bradford assay (Bio-Rad, Richmond, CA).
Cell lysates (40 μg protein per lane) were resolved by
one-dimensional SDS-PAGE and transferred to nitrocel-
lulose membranes according to standard procedures.
Equal loading of protein was verified by β-actin (Abcam,
Cambridge, MA). Membranes were washed in Tris-
buffered saline (TBS), and blocked for 2 h with TBS-
Tween (TBST) containing 10% nonfat milk, then incu-
bated with rabbit anti-human Trx1 antibody (Abcam,
Cambridge, MA) at 1:5000 dilution in TBST containing
5% nonfat milk and 0.01% sodium azide overnight at 4°C.
Membranes were washed four times with TBST for
15 min each time prior to incubation with secondary anti-
body. Western blots shown are representative blots with
their accompanying densitometric analysis.
Determination of the redox state of thioredoxin
The redox state of thioredoxin in response to crocidolite
asbestos exposure was determined using the redox
Western blot method as previously described [18].
Briefly, cells were lysed in 6 M guanidine HCl buffer
(6 M Guanidine HCl; 50 mM Tris/Cl pH 8.3; 3 mM
EDTA, 0.5% Triton X – 100; 10 μg/ml aprotonin and
10 μg/ml leupeptin) containing 50 mM iodoacetic acid
(IAA) for alkylation of the thiol groups of thioredoxin.
Cells were incubated in lysis buffer at 37°C for 30 min
Thompson et al. Particle and Fibre Toxicology 2014, 11:24 Page 3 of 13
http://www.particleandfibretoxicology.com/content/11/1/24in the dark. Excess IAA was removed by spinning lysates
on Amicon centrifugal concentrating columns with a
10,000 nominal molecular weight limit (NMWL) (EMD
Millipore, Billerica, MA). In order to exchange the IAA
containing buffer, the lysates were washed 3 times with
a HEPES buffer at pH 7.4 and the concentrated lysates
were collected in fresh collection tubes by inverting the
columns in the tubes. After protein determination by
the Bradford method (Bio-Rad, Richmond CA), 40 μg of
protein was loaded onto a 15% non–reducing native
polyacrylamide gel using a 1× Tris Glycine (pH 8.8)
running buffer. The electrophoresis was carried out at
75 V for approximately 3.5 h. The redox gel was then
washed in 50 mM Tris (pH 8.3) for 5 min and then
equilibrated in 1× transfer buffer by washing in buffer 3
times for 5 min each. Thereafter, the proteins were
transferred onto a nitrocellulose membrane by wet
transfer at 100 V for 2 h. The nitrocellulose membrane
was then blocked with 10% milk in 1× Tris buffered saline
with Tween 20 (TBS-T) for 2 h at room temperature (RT)
and incubated in anti-Trx1 primary antibody (1:5000 in
5% milk/TBS-T, Abcam, Cambridge, MA) overnight at
4°C. Goat anti–rabbit secondary antibody conjugated to
horseradish peroxidase (1:2000 in 1X TBS-T, Jackson
ImmunoResearch Laboratories Inc. West Grove, PA) was
used and visualization was done by enhanced chemilu-
minescence reagents (Amersham Pharmacia Biotech,
Piscataway, NJ) on X-ray film. Blots were quantified using
Quantity One software (Bio-Rad, Richmond, CA). Dis-
tribution of redox states of Trx1 was determined as
band intensity of reduced or oxidized Trx/(reduced +
semi-oxidized + fully oxidized) as described by Watson
et al., (2003) [18].Real-time quantitative PCR (qRT-PCR)
Total RNA was prepared using an RNeasy plus mini
kit according to the manufacturer’s protocol (Qiagen,
Valencia, CA) as described previously [15]. Total RNA
(1 μg) was reverse-transcribed with random primers using
the Promega AMV Reverse Transcriptase kit (Promega,
Madison, WI) according to the recommendations of the
manufacturer. To quantify gene expression, the cDNA
was amplified by TaqMan Real Time Q-PCR using the
7900HT SequencePrism Detector (Applied Biosystems,
Foster City, CA). Duplicate assays were performed with
RNA samples isolated from at least four independent
experiments. Fold changes in gene expression were calcu-
lated using the delta-delta Ct method. The values obtained
from cDNA and hypoxanthine phosphoribosyl transferase
(HPRT) controls helped determine relative gene expres-
sion levels for the gene locus investigated. The Assay on
Demand primers and probes used were purchased from
Applied Biosystems.Since exposure of cells to chrysotile asbestos had no
effect on the oxidation state of Trx1, all subsequent
experiments were performed using crocidolite asbestos.
All references to asbestos relate to crocidolite asbestos
unless otherwise specified.
Dehydroascorbic acid (DHA) pretreatment
In order to investigate whether the ROS generated by
asbestos exposure was responsible for the extensive oxi-
dation of thioredoxin, cells where pretreated with the
ROS quencher, dehydroascorbic acid (1 mM) for 1 h
before exposure to asbestos for 8 h.
Antioxidant pretreatment of cells by N-acetylcysteine
(NAC)
To investigate the role of the asbestos-induced ROS on
inflammasome activation, cells were pretreated with
2 mM NAC for 20 h as previously described (Shukla
et al., 2004). Briefly, cells were grown to 90% confluency
in 60 mm dishes and serum starved by replacing complete
medium with 0.5% fetal bovine serum (FBS) supplemented
medium for 6 h prior to addition of NAC diluted in HBSS
at pH 7.4 (cells were maintained in reducing medium
for the entire duration of NAC pretreatment). After pre-
treatment with NAC, cells were exposed to asbestos for
48 h. Thereafter, inflammasome priming was assessed
by qRT-PCR of NLRP3 transcript levels while activation
was analyzed by Western blot analysis of caspase-1, p20
fragment.
Treatment with 2,4-Dinitro-1-chlorobenzene DNCB
To obtain a final concentration of 10 μM in culture, 2,4-
Dinitro-1-chlorobenzene (DNCB) (an irreversible alkylating
inhibitor of TR) was dissolved in DMSO with a final DMSO
content of 0.2% which was determined to be non-cytotoxic
in previous experiments. For all experiments, cells were pre-
treated with DNCB for 1 h prior to exposure to asbestos.
Lactate dehydrogenase (LDH) activity assay
To determine the cytotoxic effects of DNCB and asbestos
exposure on LP9 cells, an LDH assay was performed using
the LDH kit from Promega, (Madison WI) according to
the manufacturer’s direction. Briefly, 50 μl of media were
collected from each dish in triplicate into a 96 well plate
using cells lysed by the addition of 0.9% Triton X-100 as a
positive control. To each of these wells, 50 μl of LDH sub-
strate buffer was added and the reaction was incubated on
a rotary shaker at room temperature for 30 min in the
dark. Thereafter, the reaction was terminated by the
addition of 50 μl stop buffer to each well. Any bubbles
present were broken with a hypodermic needle and the
plate was read spectrophotometrically at 490 nm in a 96
well plate reader. Cytotoxicity was expressed as a percent-
age of LDH released relative to the lysis control.
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To determine whether modulation of Trx1 protein
levels and oxidation state altered cell death in human
mesothelial cells, detection of apoptosis was performed
using the ApoStain technique as described previously
(Shukla et al., 2003). In brief, cells were grown on glass
cover slips and exposed to asbestos with or without
DNCB (10 μM) for 8 h. The cover slips were then proc-
essed to determine the numbers of apoptotic cells and
total cell numbers per field. Five random fields were
evaluated at a magnification of 400× on each cover slip.
Assessment of pyroptosis by asbestos
Since asbestos causes inflammasome activation, as mea-
sured by caspase-1 activation [4], we were interested in
learning if asbestos-induced cell death may be due in
part to pyroptosis (caspase-1 dependent cell death) or
not. For this purpose we pretreated LP9 cells with a spe-
cific caspase-1 inhibitor (40 μM Caspase-1 inhibitor VI
(zYVADfmk), EMD Biosciences, Billerica, CA) for 1 h
and subsequently with asbestos for 24 h. The number of
viable cells was determined after trypsinization and
counting of cells on a hemocytometer at the end of the
experiment. Media supernatants were also analyzed for




Cells at 90% confluence were transfected with pcDNA
(empty vector control, 4 μg DNA per 60 mm dish) and
human Trx1 over expression vector (pCMV-SPORT6,
4 μg DNA per 60 mm dish) using Lipofectamine 2000
(10 μl) (Life Technologies, Grand Island, NY), following
the manufacturer’s protocol. The efficiency of Trx1 pro-
tein over expression was determined by qRT-PCR after
48 and 72 h.
Knockdown of TXNIP
LP9 cells that were 90% confluent were transfected with
either ON-TARGET plus smart pool human TXNIP
siRNA (siTXNIP) or ON-TARGET plus non-targeting
siRNA (siControl) from Dharmacon (Fisher Scientific,
Pittsburgh, PA) using Lipofectamine 2000 (Life Tech-
nologies, Grand Island, NY) diluted in a final volume of
500 μl Optimem medium (Life Technologies, Grand
Island, NY), as previously described [15]. All siRNA
were reconstituted to 20 μM before transfection and
stored at -20°C until use. The magnitude of TXNIP
knockdown was assessed by qRT-PCR.
To confirm observations of the role of TXNIP in
inflammasome activation, a human mesothelioma cell
line (HMESO) in which the extracellular signal regulated
kinase 2 had been stably knocked down (shERK2) wasused. These cells have been previously reported (GSE21750)
to have down-regulated expression of TXNIP (several
fold). To activate the inflammasome, shERK2 HMESO
cells and corresponding control cells stably transfected
with non-targeting shRNA (shCon) were treated with
5 μM doxorubicin (Dox) as previously described [19].
After 48 h of treatment the shERK2 and shCon HMESO
cells, treated with or without Dox, medium supernatants
were harvested by centrifuging medium at 300 × g for
7 min in the cold (4°C) to remove cellular debris. The
resulting supernatants, stored in 1 ml aliquots, were
concentrated using Amicon centrifugal concentrating
columns with a 10,000 nominal molecular weight limit
(NMWL) (EMD Millipore, Billerica, MA). 4× sample
buffer was added to the concentrated supernatant to a
final concentration of 1× before being electrophoresed
at 100 V for 2 h on a 15% SDS PAGE gel. Immunoblot-
ing was performed as described above with caspase-1
p20 antibody (Cell Signaling, Danvers MA) to detect
caspase-1 activation.
Statistical analysis
All data were analyzed by one-way ANOVA compared
with the respective control group and a Neuman-Keuls
post test for multiple comparisons or the Student’s
‘t’test. Results are presented as the mean ± SEM. All
experiments were repeated at least twice or more.
Comparisons with a p value ≤ 0.05 were considered
statistically significant. Statistical analyses were con-
ducted using Graph Pad Prism v6 software.
Results
The effects of crocidolite asbestos exposure on thioredoxin
1 (Trx1) expression in human mesothelial cells
To determine the effect of crocidolite asbestos exposure
on the expression levels of Trx1, LP9/h-TERT cells were
exposed to 75 × 106 μm2/cm2 (or 5 μg/cm2 ) crocidolite
for 8 and 24 h and RNA was extracted. Analysis of fold
changes in mRNA levels for Trx1 by qRT-PCR revealed
a 1.6 fold increase in Trx1 mRNA levels after 24 h of
crocidolite asbestos exposure as compared to controls
(*p < 0.05) (Figure 1A). An assessment of the total Trx1
protein levels after crocidolite asbestos exposure showed
a decrease in protein levels after 24 h (Figure 1B & C).
In contrast, glass beads (which were used as a negative
control) and crocidolite asbestos at surface area coverage
of 15 × 106 μm2/cm2 (or 1 μg/cm2) did not cause a sig-
nificant increase in mRNA levels at 24 h as compared to
untreated controls.
The oxidation state of thioredoxin 1 (Trx1) after
crocidolite exposure
LP9 cells exposed to 75 × 106 μm2/cm2 crocidolite asbes-
tos for 8 and 24 h showed a decrease in the proportion of
Figure 1 Crocidolite asbestos exposure modulates Trx1 levels
in mesothelial cells. (A) LP9 cells were exposed to crocidolite
asbestos at 75 × 106 μm2/cm2 for 8 and 24 h. Glass beads (GB) at
the same surface area concentration were used as an inert particulate
control. RNA was extracted from the samples and used to prepare
cDNA, which was quantified by qRT-PCR (*p < 0.05 compared to
untreated controls (NC)). (B) Western blot analysis of LP9 cells for
total thioredoxin protein after exposure to crocidolite asbestos, β-actin
was used as a loading control. (C) densitometric analysis of (B) using
Quantity One software (n =2 per group) .
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compared to untreated controls (Figure 2A). This decrease
in the level of reduced thioredoxin was not observed in
cells treated with sodium arsenite, which has been shown
previously to oxidize Trx1 in a different cell type [20]. In
addition, the total amounts of Trx1 observed in crocidolite
asbestos exposed cells appeared to be lower than the levels
in the other treatment groups. A third band that repre-
sented fully oxidized thioredoxin was present in cells
exposed to either crocidolite asbestos or arsenite, but was
not observed in lysates from the untreated controls. Todetermine whether the oxidation of thioredoxin by cro-
cidolite was specific to crocidolite asbestos alone, LP9
cells were also exposed to chrysotile asbestos and glass
beads. As assessed by redox Westerns, oxidation of thiore-
doxin was specific to the higher concentration (75 ×
106 μm2/cm2) of crocidolite asbestos alone (Figure 2C).
Levels of reduced and semi-oxidized Trx1 remained the
same at 8 and 24 h in response to chrysotile and glass
bead exposure.
Inhibition of thioredoxin reductase (TR) by
dinitrochlorobenzene (DNCB) and pretreatment with
dehydroascobic acid
To determine whether inhibition of TR by DNCB would
increase asbestos-induced oxidation of Trx1, LP9 cells
were pretreated with 10 μM DNCB and exposed to 75 ×
106 μm2/cm2 crocidolite asbestos for 8 and 24 h. A
lactate dehydrogenase (LDH) assay performed on the
medium from exposed cells showed that LDH levels
were reduced in cells pretreated with DNCB when com-
pared with cells exposed to asbestos alone (Figure 3A).
In addition, redox Western blot analysis of cell lysates
indicated that the oxidation of Trx1 by asbestos was
ameliorated when cells were pretreated with DNCB be-
fore exposure to crocidolite asbestos (Figure 3B). On the
contrary, cells exposed to chrysotile asbestos with and
without DNCB showed no changes in the redox states of
Trx1 when compared to controls (Figure 3C). An Apos-
tain assay to detect chromatin condensation and single
strand breaks in nuclear DNA as a measure of early
apoptotic events was also conducted to determine the
effects of pretreatment with DNCB on asbestos-induced
apoptosis. Apostain revealed that cells pretreated with
DNCB were protected from apoptosis after 8 h of expos-
ure to crocidolite asbestos (Figure 3D). On the other
hand, pretreatment of LP9 cells with DHA before expos-
ure to asbestos slightly increased the amount of reduced
thioredoxin in cells compared to asbestos exposure
alone (Figure 3E). However, there was no significant in-
crease when compared to control or asbestos exposure
alone.
ROS generation in response to asbestos is modulated by
Trx1 in LP9 cells
To assess ROS generation after exposure to asbestos,
90% confluent LP9 cells were exposed to 75 × 106 μm2/cm2
asbestos for 24 h and incubated with NBT as described
in the methods. Spectrophotometric assessment of the
solubilized formazan revealed a significant increase in
ROS levels when compared to controls (Figure 4A).
Quantitative RT-PCR performed on cDNA from Trx1
over-expressing cells and their respective controls indi-
cated a 4 fold increase in Trx1 levels after 48 h of trans-
fection and this was reduced by approximately 50% 72 h
Figure 2 Crocidolite asbestos exposure causes oxidation of Trx1 in human mesothelial cells. (A) LP9/h-TERT cells were exposed to
crocidolite asbestos at 75 × 106 μm2/cm2 for 8 and 24 h and 40 μg of protein was run on a 15% native gel and a redox Western blot analysis
was performed as described in the Methods section on the immobilized proteins. (B) Quantitation of the blot in (A). (C) Cells were exposed
to two concentrations of crocidolite asbestos (15 × 106 μm2/cm2 and 75 × 106 μm2/cm2), as well as chrysotile asbestos (75 × 106 μm2/cm2)
and a redox Western analysis was performed on the lysates (*p < 0.05 compared to null controls (n = 2 per group).
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expression on asbestos-induced ROS generation and
cell survival was assessed by exposing 90% confluent
LP9 cells transfected with a Trx1 over-expression vector
(pCMV-SPORT6) and empty vector transfected controls
(pcDNA) to 75 × 106 μm2/cm2 crocidolite asbestos for
2 h. The levels of ROS generated in response to asbestos
exposure were then measured as described previously.
Cells over-expressing Trx1 were found to exhibit a
trend of reduced ROS levels compared to the null con-
trols exposed to asbestos (Figure 4C). It is to be noted
here that the amount of ROS generated by asbestos
after 2 h of exposure is significantly lower in magnitude
than 24 h after asbestos exposure (Figure 4A). An as-
sessment of the redox state of Trx1 in Trx1 over-
expressing cells after asbestos exposure indicated that
levels of reduced Trx1 were rescued in over-expressing
cells as compared to control cells transfected with empty
vector (EV) alone (Figure 4D). Additionally, cells over-
expressing Trx1 also had increased cell survival after ex-
posure to crocidolite asbestos (Figure 4E).
Effect of N-acetyl-cysteine (NAC) on asbestos-induced
inflammasome activation
Asbestos exposure results in the generation of ROS in
LP9 cells, and ROS has been reported to be one of the
activators of the NLRP3 inflammasome [5]. To deter-
mine whether asbestos-induced ROS plays a role in
inflammasome activation, LP9 cells were pretreated with
NAC and analyzed for inflammasome priming and acti-
vation by qPCR and Western blot analysis. A decrease in
steady-state NLRP3 transcript levels was observed in cells
pretreated with NAC prior to asbestos exposure whencompared to cells exposed to asbestos alone (Figure 5A).
However, this decrease in NLRP3 transcript levels with
NAC pretreatment was not statistically significant. Con-
currently, levels of active caspase 1 secreted into the
medium after exposure of LP9 cells to asbestos were
also significantly reduced after pretreatment with NAC
(Figure 5B).
TXNIP down-regulation attenuated asbestos-induced
inflammasome activation
Validation of the knockdown of TXNIP expression by
siTXNIP was determined by qRT-PCR and showed that
an approximately 50% reduction in TXNIP mRNA levels
was achieved after 48 h of transfection (Figure 6A).
Western blot analysis of the cell medium after exposure
to asbestos for 48 h indicated that active caspase 1 levels
(caspase1-p20) were reduced after knockdown of TXNIP
when compared to siControl transfected cells (Figure 6B).
In mesothelioma cell lines with a stable knockdown of
extracellular signal regulated kinase 2 (shERK 2), the
expression of TXNIP was found to be down-regulated
4-fold (Figure 6C). Activation of the NLRP3 inflamma-
some by doxorubicin treatment of shERK2 HMESO cells
indicated that caspase 1 activation was drastically re-
duced as compared to control cells stably transfected
with non-targeting shRNA (shCon) (Figure 6D) and
there was no priming of NLRP3 as measured by mRNA
levels of NLRP3 using qRT-PCR (Figure 6C).
Caspase-1 dependent cell death (pyroptosis), which
may occur in response to inflammasome activation, may
contribute to asbestos-induced cell death in addition to
asbestos-induced apoptosis and lytic cell death. There-
fore, we sought to determine whether pyroptotic cell
Figure 3 Inhibition of thioredoxin reductase by DNCB and pretreatment of cells with DHA rescues asbestos-induced oxidation of Trx1.
(A) LDH assay to assess lytic cell death after pretreatment of LP9 cells with DNCB and exposure to asbestos (data is presented as a percentage of
the lytic control). (B) Effect of DNCB on asbestos-induced Trx1 oxidation. Cells were pretreated with 10 μM DNCB for an hour and then exposed
to asbestos for 8 h. Cell lysates were then derivatized with IAA and analyzed for oxidation of Trx1 by redox Western blot and densitometry of
redox Western analysis of Trx1 oxidation state was performed. (C) Effect of DNCB pretreatment on chrysotile asbestos-induced oxidation of Trx1
(D) Analysis of apoptosis in response to DNCB pretreatment and asbestos exposure for 8 h as measured by Apostain technique. (E) LP9 cells were
pretreated with 1 mM DHA for an hour and exposed to asbestos for 8 h. Thereafter, the oxidation state of Trx1 was assessed by redox Western
blot analysis (*p < 0.05 compared to null controls; †p < 0.05 compared to crocidolite asbestos exposure alone (Croc 75 n = 2 per group).
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masome activation. To do so, LP9 cells were pretreated
with 40 μM Caspase-1 inhibitor VI (zYVAD-FMK)
before exposure to asbestos. When compared to cells
exposed to asbestos alone, there was an 18% increase in
cell viability, suggesting this fraction of cells may have
undergone pyroptotic cell death upon exposure to
asbestos (Figure 6E). Immunoblotting for Cas-1 p20 in
concentrated medium supernatants also confirmed that
the inhibitor attenuated activation of the caspase-1 as
expected (Figure 6F).Discussion
Reactive oxygen species generated in response to asbes-
tos exposure have been shown to have deleterious effects
in different cell types. Asbestos-induced ROS generation
has been shown to cause oxidative damage to mitochon-
drial and genomic DNA [21,22] and may modulate the
activity/function of various signaling molecules, tran-
scription factors and enzymes that are redox sensitive
[11,21,23]. The high iron content as well as the valency
state of iron on crocidolite asbestos fibers has been
shown to facilitate Fenton reactions both intracellularly
Figure 4 Over-expression of Trx1 increases cell survival and ameliorates asbestos-induced ROS generation in LP9 cells. (A) LP9 cells
were exposed to two doses of crocidolite asbestos (15 × 106 μm2/cm2 and 75 × 106 μm2/cm2) for 24 h and incubated with NBT for 45 min at
37°C. The absorbance of the solubilized formazan formed after incubation with NBT was then read at 630 nm to determine ROS levels after
asbestos exposure. (B) Over-expression of Trx1 in LP9 cells using the pCMV-SPORT6 plasmid was confirmed by qRT-PCR 48 and 72 h after transfection.
(C) Trx1 transfected cells were exposed to crocidolite asbestos for 2 h and incubated with NBT for 45 min to determine ROS levels. Solubilized
formazan was measured spetrophotometrically at 630 nm on a plate reader. (D) Analysis of the oxidation state of Trx1 after asbestos exposure
of Trx1 over-expressing LP9 cells was determined by redox Western blot analysis and densitometry of the blot was performed (n = 2 per group).
(E) LP9 cells transfected with the Trx1 over-expressing plasmid, pCMV-SPORT6 were exposed to crocidolite asbestos for the times indicated.
Cells were then trypsinized and counted to estimate cell survival (*p < 0.05 compared to control; †p < 0.05 compared to Trx1 OE). Cell survival
and NTB graphs are the average results of 3 experiments.
Thompson et al. Particle and Fibre Toxicology 2014, 11:24 Page 8 of 13
http://www.particleandfibretoxicology.com/content/11/1/24and extracellulary [24,25]. Mitochondrial generated super-
oxide can react with Fe3+ ions on asbestos fibers to
reduce it to Fe2+ [25]. Unfortunately, this enables the Fe2+
to react with any H2O2 present in the cell to produce
hydroxyl radicals. This can lead to a cycle of oxidation and
reduction of Fe3+ to produce more ROS. Additionally, the
high aspect ratio of the crocidolite asbestos fibers leads to
frustrated phagocytosis as mesothelial cells try to unsuc-
cessfully phagocytose the fibers [5]. Frustrated phago-
cytosis promotes a sustained production of superoxide
through the activity of membrane bound NADPH oxi-
dases that are activated during the repeated phagocyt-
osis attempts [26]. Asbestos exposure has been shown
to cause a depletion of reduced glutathione levels
in vitro [10,11], but its effects on Trx, another major
antioxidant of the cell, is unknown. The ability of cro-
cidolite asbestos fibers to activate the inflammasome inmacrophages and mesothelial cells [4,5] and the in-
volvement of the endogenous inhibitor of Trx, TXNIP,
in activation of the NLRP3 inflammasome [9] led us to
hypothesize that oxidation of Trx by asbestos-induced
ROS may cause the dissociation of TXNIP from Trx
and lead to activation of the inflammasome. Here we
show for the first time that asbestos exposure of human
mesothelial cells leads to oxidation of Trx and a com-
pensatory increase in Trx1 transcript levels. We also
report that TXNIP is involved in asbestos mediated
activation of the inflammasome which may be as a
result of the oxidation of Trx1 by asbestos-induced
ROS generation.
Quantitative real time PCR showed that asbestos
exposure increased the steady-state RNA levels of Trx1
by approximately 1.6 fold after 24 h. The promoter of
the Trx gene (TXN) contains an antioxidant response
Figure 5 Asbestos-induced inflammasome priming and
activation is attenuated by NAC. (A) LP9 cells pretreated with
2 mM NAC were exposed to 5 ug/cm2 asbestos for 48 h and changes
in NLRP3 mRNA levels were assessed by qRT-PCR. (B) Inflammasome
activation was assessed by Western blot analysis of the media
supernatants from cells exposed to asbestos with and without
pretreatment with NAC. Immobilized proteins on the nitrocellulose
membrane were probed for the presence of active caspase-1 (p20
fragment) (*p < 0.05 compared to null control; † compared to Croc
75 alone; n = 2 per group).
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ated in response to asbestos exposure led to an increase in
Trx1 expression as a compensatory mechanism by activat-
ing ARE-dependent gene expression. It has been reported
by our group that cells exposed to asbestos show increased
expression of the mitochondrial manganese superoxide
dismutase (MnSOD) [11]. Studies also show that increases
in expression of cellular antioxidant proteins (MnSOD
and Trx1) occur in response to oxidative stress [10,11].
Exogenous thioredoxin as well as endogenously over-
expressed Trx has also been shown to increase MnSOD
levels in a redox dependent manner [28]. As such,
increases in ROS generation in LP9 cells exposed to
asbestos coupled with the oxidation of Trx1 and in-
creased transcription of Trx1 could be considered an
indication of asbestos-induced oxidative stress. To the
contrary, the total intracelluar protein levels of Trx1
were reduced by about 67% in response to asbestos
exposure after 24 h (Figure 1B, C). This suggests that,
ROS generation by asbestos exposure may lead to anincreased oxidation and removal of Trx1 protein as a
conjugate, and the cells may increase transcription as a
compensatory mechanism. However, Trx1 is secreted into
the culture medium in response to many stimuli – it may
not be degraded [29,30]. Similarly, we have demonstrated
previously that asbestos exposure depletes glutathione
from cells while increasing the steady-state RNA levels of
γ-glutamylcysteine synthetase (a rate limiting enzyme for
glutathione synthesis) at the same time [10].
To determine if asbestos exposure causes changes in
the antioxidant capacity of Trx1, the oxidation state of
Trx1 was assessed by redox Western blot analysis after
exposure of LP9 cells to asbestos. The analysis of the
oxidation states of Trx1 after asbestos exposure showed
that Trx1 became irreversibly oxidized and levels of
reduced Trx1 were drastically decreased compared to
control cells. The diminution in the levels of reduced
Trx1 may be due to the oxidation of the structural cyst-
eine residues (Cys 62, 69 and 73). Oxidation of these
structural cysteines can lead to disulfide bond formation
between Cys 62 and 69 which has been shown to re-
duce the use of Trx1 as a substrate for TR [18]. As a
result, Trx1 cannot be reduced to its active form. The
formation of disulfide bonds between Cys 73 of two
adjacent Trx1 molecules leading to their dimerization
has also been shown to occur under extremely oxidiz-
ing conditions [31]. This dimerization may lead to con-
formational changes in the active site of Trx1 which
will make the active site Cys residues inaccessible to
TR for reduction. Other studies have shown that strong
oxidants can cause the oxidation of Trx1 producing a
mixture of Trx1 monomers, dimers and oligomers with
no free sulfhydryl groups [32]. These findings support
the possibility that asbestos-induced ROS may be in-
volved in directly or indirectly altering the oxidation
state of Trx1.
Maintenance of the reducing milieu of the cell is also
important for cell survival; thus, imbalances in the ratio
of cellular antioxidants and oxidants could lead to dele-
terious or lethal effects on the cell. To investigate what
role perturbations in the redox state of the thioredoxin
system plays in asbestos-induced cell death, LP9 cells
were pretreated with dinitrochlorobenzne (DNCB), an
irreversible alkylating inhibitor of TR [33] and assessed
for cell death in response to asbestos exposure. An LDH
assay as well as the Apostain assay showed that pretreat-
ment with DNCB protected cells from asbestos induced
cell death contrary to all reports in the literature in
which treatment of cells with DNCB resulted in cell
death [34-36]. In contrast, recent studies have shown
that inhibition of TR leads to increases in GSH levels
and a reduction of Trx1 and Trx2 by glutaredoxin in the
absence of a functional TR enzyme [37,38]. It is there-
fore likely that the protection of human mesothelial cells
Figure 6 Knockdown of TXNIP decreases inflammasome activation. (A) LP9/hTERT cells (90% confluent) were transiently transfected with
siTXNIP or siControl siRNA for 48 h and knockdown of TXNIP expression was assessed by qRT-PCR. (*p < 0.05 compared to siControl) (B) siControl
and siTXNIP transfected cells were exposed to crocidolite asbestos for 48 h and the medium were collected, concentrated and analyzed for the
presence of caspase-1 (p20) by Western blot analysis. (C) The transcript levels of ERK 1/2 as well as TXNIP were verified in shERK2 HMESO cells by
qRT-PCR in the presence and absence of 5 μM Dox along with priming of the inflammasome (*p < 0.05 compared to shCon alone; †p < 0.05
compared to shCon +Dox; n = 2 per group). (D) Inflammasome activation was assessed by Western blot analysis for the p20 fragment of caspase-1 in
the media supernatants after treatment with Dox (*p < 0.05 compared to shCon alone; †p < 0.05 compared to shCon + Dox; n = 2 per group). (E) LP9
cells were pretreated with 40 μM of the caspase-1 inhibitor VI (cas-1 inh) prior to exposure to asbestos for 48 h and cells were counted to determine
survival (*p < 0.05 compared to control; †p < 0.05 compared to Croc 75 alone). (F)Western blot analysis for Cas-1 p20 fragment in medium supernatant
from LP9 cells pretreated with the caspase-1 inhibitor prior to exposure to asbestos (n = 3 per group).
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DNCB may be due to increases in GSH and levels of
reduced Trx1.
Levels of intracellular GSH are sensitive to ROS levels
[39] and are modulated upon exposure of cells to asbes-
tos [10,11]. Reactive oxygen species have also been
shown to play a role in the activation of the NLRP3
inflammasome after asbestos exposure [6] and may be
linked to the effects of GSH levels on Trx1 oxidation
state and the availability of TXNIP to bind to and acti-
vate the inflammasome. To test the effect of increased
GSH or reduced ROS levels on inflammasome activa-
tion, LP9 cells were incubated with 2 mM NAC for 20 hprior to asbestos exposure and this led to a significant
decrease in inflammasome activation, as well as a reduc-
tion in priming. This suggests that high GSH levels may
buffer reduced Trx1 levels [38] and prevent the disso-
ciation of TXNIP from Trx1. As such, TXNIP is unable
to bind to and activate the inflammasome leading to
reduced levels of Caspase-1 p20 peptides in the medium
supernatant. The reduction in priming of the NLRP3
may also be due to the decrease in ROS levels as GSH
levels increased to buffer cells from the ROS generated
in response to asbestos exposure since transcription of
NLRP3 is under the control of NFκB (a redox sensitive
transcription factor) [40-42]. Exposure of LP9 cells to
Figure 7 Role of ROS and antioxidants in asbestos-induced
activation of the NLRP3 inflammasome. A simplified schema
showing how increased ROS or decreased GSH as a result of
asbestos exposure can cause oxidation of Trx1 and release of TXNIP.
TXNIP thus released binds to NLRP3 and activates it as represented
by caspase-1 activation. NAC on the other hand reduces ROS and
elevates GSH levels resulting in inhibition of activation of NLRP3.
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duced by asbestos as there was no significant increase
when compared to control (data not shown). This
implies that the oxidative stress induced by asbestos
exposure is ameliorated by NAC.
We have demonstrated previously that crocidolite
asbestos causes cell death and compensatory prolifera-
tion [3], which may be a required step for crocidolite
asbestos-induced cell transformation and MM develop-
ment. Our results here, indicate that a fraction of total
cell death by asbestos is caused by pyroptosis (caspase-1
dependent cell death, Figure 6), a process known to be
regulated in part by TXNIP. However, this observation
needs to be confirmed using siRNA mediated knock-
down of caspase-1 in future studies. We suspect that
pyroptosis is prevented by over-expression of Trx1
(Figure 4) which renders TXNIP unavailable to subse-
quently induce inflammasome assembly and thus,
caspase-1 activation.
Assessment of the effects of Trx1 over-expression on
asbestos-induced ROS generation revealed that LP9
cells over-expressing Trx1 had lower levels of ROS after
asbestos exposure when compared to vector transfected
cells. Although asbestos induced a significant increase
in ROS generation in LP9 cells after 24 h, the trend of
reduction in ROS levels with Trx1 over-expression at an
earlier time point (2 h) were not statistically significant,
but reproducible. The reduction in asbestos-induced
ROS generation in LP9s over-expressing Trx1 also cor-
responded to a moderate increase in cell survival which
also exhibited a trend. Cells undergoing oxidative stress
up-regulate the expression of antioxidant proteins like
thioredoxin and MnSOD as well as the antioxidant pep-
tide glutathione to counter the increase in oxidant levels
[10,11,43]. As such, the reduction in asbestos-induced
ROS levels upon over-expression of Trx suggests that
the increase in Trx1 levels after asbestos exposure may be
a compensatory mechanism to restore the antioxidant-
oxidant balance that is disrupted by asbestos [21].
Our study also showed that the redox-dependent Trx-
TXNIP interaction is involved in asbestos-induced
inflammasome activation. When TXNIP, the negative
regulator of Trx1 reductase activity, was knocked down
in LP9 cells, inflammasome activation was reduced.
Cells transfected with siTXNIP had decreased amounts
of active Caspase-1 subunit p20 in the medium after
exposure to asbestos when compared to control. Add-
itionally, activation of the inflammasome by the che-
motherapeutic doxorubicin in shERK2 HMESO cells,
which have a four-fold lower expression of TXNIP, was
attenuated, confirming that TXNIP is required for
inflammasome activation. In support of our data, Zhou
et al. [9] demonstrated that knockdown of TXNIP by
siRNA in beta islet cells reduced activation of theNLRP3 inflammasome. Thus our findings corroborate
the role of TXNIP in inflammasome activation by asbes-
tos, and relate inflammasome activation via TXNIP to
ROS levels in the cell (Figure 7).
Conclusion
This study has demonstrated that activation of the
inflammasome by asbestos is mediated in part by TXNIP
as a consequence of alterations in the redox state of
Trx1 in the cytosol. Further studies are in progress to
offer an understanding of how asbestos-induced activa-
tion of the inflammasome and subsequent generation of
biomolecules (IL-1β, IL-18, HMGB1 etc.) may lead to
mesothelial cell transformation events and mesothelioma
development.
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